Covered recipient · General Payments record
JESSICA J HANSEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,642.85
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $723.71 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $230.84 | 8 |
| Mylan Specialty L.P. | $124.99 | 1 |
| Acerta Pharma LLC | $119.74 | 1 |
| GENZYME CORPORATION | $106.05 | 1 |
| Biogen, Inc. | $61.43 | 1 |
| Lundbeck LLC | $33.56 | 1 |
| Lilly USA, LLC | $33.18 | 2 |
| Currax Pharmaceuticals LLC | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $119.74 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105783162 | CMS |
| Biogen, Inc. | $61.43 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104850418 | CMS |
| Currax Pharmaceuticals LLC | $13.92 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089522292 | CMS |
| GENZYME CORPORATION | $106.05 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139988651 | CMS |
| Lilly USA, LLC | $15.62 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135706758 | CMS |
| Lilly USA, LLC | $17.56 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135706760 | CMS |
| Lundbeck LLC | $33.56 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146031710 | CMS |
| Mylan Specialty L.P. | $124.99 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147286144 | CMS |
| Novo Nordisk Inc | $13.11 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100617368 | CMS |
| Novo Nordisk Inc | $21.32 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100350406 | CMS |
| Novo Nordisk Inc | $12.66 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100245851 | CMS |
| Novo Nordisk Inc | $116.97 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100263372 | CMS |
| Novo Nordisk Inc | $22.65 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100582370 | CMS |
| Novo Nordisk Inc | $18.87 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100577778 | CMS |
| Novo Nordisk Inc | $13.02 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100292811 | CMS |
| Novo Nordisk Inc | $12.24 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100277324 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.